Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery

The number of agents that are potentially effective in the adjuvant treatment of locally advanced resectable colon cancer is increasing. Consequently, it is important to ascertain which subgroups of patients will benefit from a specific treatment. Despite more than two decades of research into the m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tejpar, Sabine, Bertagnolli, Monica, Bosman, Fred, Lenz, Heinz-Joseph, Garraway, Levi, Waldman, Frederic, Warren, Robert, Bild, Andrea, Collins-Brennan, Denise, Hahn, Hejin, Harkin, D. Paul, Kennedy, Richard, Ilyas, Mohammad, Morreau, Hans, Proutski, Vitali, Swanton, Charles, Tomlinson, Ian, Delorenzi, Mauro, Fiocca, Roberto, Van Cutsem, Eric, Roth, Arnaud
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2010
Matèries:
Academia-Pharma Intersect
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227961/
https://ncbi.nlm.nih.gov/pubmed/20350999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0233
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars